Literature DB >> 9324363

ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors.

D A Lammas1, C Stober, C J Harvey, N Kendrick, S Panchalingam, D S Kumararatne.   

Abstract

The death of BCG-infected human macrophages induced in vitro by ligation of surface CD95 (Fas), CD69, or complement-mediated lysis was shown not to result in the death of intracellular mycobacteria, whereas exposure to extracellular ATP initiated both macrophage death and killed the intracellular bacteria. ATP acted via P2Z receptors because these effects were mimicked by benzoylbenzoic ATP (a known agonist of P2Z receptors) and blocked by oxidized ATP, DIDS, suramin, amiloride, and KN62 (known inhibitors of P2Z-mediated responses). ATP-mediated bacterial killing was independent of reactive nitrogen and oxygen intermediates and of actinomycin D or cycloheximide inhibition. ATP-induced macrophage cell death, BCG killing, and lucifer yellow dye incorporation were minimal in 2 out of 19 healthy donors. The results suggest possible genetic heterogeneity of this mechanism of mycobacterial killing associated with P2Z-mediated pore formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324363     DOI: 10.1016/s1074-7613(00)80364-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  120 in total

Review 1.  Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation.

Authors:  G Haskó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  ATP and control of intracellular growth of mycobacteria by T cells.

Authors:  David H Canaday; Reza Beigi; Richard F Silver; Clifford V Harding; W Henry Boom; George R Dubyak
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.

Authors:  T Shimizu; C Sano; H Tomioka
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 4.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

5.  Functional evidence of distinct ATP activation sites at the human P2X(7) receptor.

Authors:  M Klapperstück; C Büttner; G Schmalzing; F Markwardt
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

6.  P2X(7) receptor and macrophage function.

Authors:  Mark D Wewers; Anasuya Sarkar
Journal:  Purinergic Signal       Date:  2009-02-13       Impact factor: 3.765

7.  The role of P2 receptors in controlling infections by intracellular pathogens.

Authors:  Robson Coutinho-Silva; Cristiane Monteiro da Cruz; Pedro M Persechini; David M Ojcius
Journal:  Purinergic Signal       Date:  2007-01-12       Impact factor: 3.765

8.  Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.

Authors:  Sahil Adriouch; Felix Scheuplein; Robert Bähring; Michel Seman; Olivier Boyer; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Purinergic Signal       Date:  2009-02-21       Impact factor: 3.765

9.  Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections.

Authors:  Ranu Surolia; Suman Karki; Zheng Wang; Tejaswini Kulkarni; Fu Jun Li; Shikhar Vohra; Hitesh Batra; Jerry A Nick; Steven R Duncan; Victor J Thannickal; Adrie J C Steyn; Anupam Agarwal; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

10.  Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor/NADPH-oxidase signalling and contributes to persistence.

Authors:  Chul Hee Choi; Ralee Spooner; Jefferson DeGuzman; Theofilos Koutouzis; David M Ojcius; Özlem Yilmaz
Journal:  Cell Microbiol       Date:  2013-01-09       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.